National HIV PrEP CurriculumLogo

Lesson 2. HIV PrEP for Women

 Next Back

Learning Objective Performance Indicators

  • Explain how intimate partner violence impacts the risk for HIV acquisition among women, including pregnant women
  • Provide a rationale for prescribing HIV PrEP for women of childbearing age
  • Summarize the HIV epidemiology, clinical trial evidence, and indications that support the use of HIV PrEP in women and in pregnant women
  • Explore the risks and benefits of using HIV PrEP in pregnant women during the periconception period, pregnancy, or with breastfeeding
  • Discuss the clinical management of HIV PrEP for women and pregnant women including sexual history, baseline evaluation, HIV PrEP medications, follow-up monitoring, and adherence

About this Lesson

Learning Objective Performance Indicators

  • Explain how intimate partner violence impacts the risk for HIV acquisition among women, including pregnant women
  • Provide a rationale for prescribing HIV PrEP for women of childbearing age
  • Summarize the HIV epidemiology, clinical trial evidence, and indications that support the use of HIV PrEP in women and in pregnant women
  • Explore the risks and benefits of using HIV PrEP in pregnant women during the periconception period, pregnancy, or with breastfeeding
  • Discuss the clinical management of HIV PrEP for women and pregnant women including sexual history, baseline evaluation, HIV PrEP medications, follow-up monitoring, and adherence

Activities in this Lesson

Share by e-mail

Check
-On-
Learning
Questions
The Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.

You must be signed in to customize your interaction with these questions.

The Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS) and Centers for Disease Control and Prevention (CDC) provided financial support for this (website, PowerPoint, podcast, mini-lecture, etc.). The award provided 100% of total costs and totaled $299,994 from HRSA and $603,203 from CDC. The contents are those of the author. They may not reflect the policies of HRSA, HHS, CDC, or the U.S. Government.

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.